Jenn Adams
Senior Advisor at Oak HC/FT
Nashville, Tennessee
Overview
Work Experience
Chief Executive Officer
2020 - Current
August Bioservices is a CDMO comprised of a team of highly experienced scientists and professionals, providing a comprehensive service offering to advance drug discovery, pharmaceutical development, and manufacturing for the pharmaceutical and biotechnology industries. August Bioservices is uniquely positioned to support individual projects, or to serve as an extension of its customers’ development teams. August Bioservices is scaling its capabilities to support commercial liquid and lyophilized vial filling demand, prefilled syringe & cartridge filling and IV Bag filling and terminal sterilization.
Senior Advisor
2019
I am responsible for developing and advising new healthcare tech-enabled businesses through a combination of building from scratch and investing in early- and growth-stage companies. Together with the exceptional investment team at Oak HC/FT, we will focus on enabling companies and entrepreneurs who provide value through patient-centric solutions.
Oak HC/FT is a venture and growth equity investment firm that focuses on healthcare information services and financial service technology.
Member Board Of Directors
2021
Eton Pharmaceuticals develops proprietary formulations of approved molecules in ways that offer improvements for patients and physicians.
Raised $38,100,000.00 from Liquid Ventures and Liquid Ventures.
SVP & President, Clinical Product Solutions
2015 - 2018
Led the 2000-employee Clinical Products Solutions business with full P&L responsibility for finance, sales, marketing, operations, supply chain, business development and human resources.
Vice President Sales/National Accounts
2008 - 2015
Drove commercial growth for this PE backed start-up in the US market. Captured double digit growth YoY, catapulting annual revenue from $58M to $700M. Reported to the CEO and led commercial team of 85 in sales, national accounts and inside sales for the acute care, hospital market segment and ambulatory surgery center markets.
Distribution of special products.
VP Sales
2004 - 2008
Led sales, clinical education and sales training functions for Baxter’s $270M US Transfusion Therapies division following Fenwal’s divestiture from Baxter. Managed a team of 150 employees and led the seamless transition of commercial business to a private, stand-alone business following its acquisition by a PE firm.
Senior Director Of Marketing
2001 - 2004
Designed a strategic marketing plan for 2 U.S. businesses, which delivered a combined $600M in sales. Managed a team of 23 marketing professionals in creation of franchise level strategic plans and marketing plans within the US infusion systems market space.
AVP Sales
1999 - 2001
Led Sales team of 6 Acute Care Region Managers and 55 Territory Managers in Baxter's Infusion Systems division. Responsible for annual revenue contribution of $303M in capital equipment. Additionally, led a team in the Alternate Site business that included a Region Manager and 8 territory managers with a combined hardware budget of $16M.
Early Career Experience - Progessive roles in Sales and Marketing
1991 - 1999
Held multiple roles with increasing responsibility within the Sales and Marketing functions of Baxter's Medication Delivery Business.